← Back to Screener
Tivic Health Systems, Inc. Common Stock (TIVC)
Price$1.13
Favorite Metrics
Price vs S&P 500 (26W)-70.55%
Price vs S&P 500 (4W)8.38%
Market Capitalization$3.02M
All Metrics
Book Value / Share (Quarterly)$3.36
P/TBV (Annual)0.88x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-14.77%
Cash Flow / Share (Quarterly)$-3.99
Price vs S&P 500 (YTD)-30.23%
Gross Margin (TTM)-58.09%
Net Profit Margin (TTM)-1557.26%
EPS (TTM)$-9.87
10-Day Avg Trading Volume0.07M
EPS Excl Extra (TTM)$-9.87
Revenue Growth (5Y)13.18%
EPS (Annual)$-19.68
ROI (Annual)-223.08%
Gross Margin (Annual)0.26%
Net Profit Margin (5Y Avg)-614.40%
Cash / Share (Quarterly)$2.07
Revenue Growth QoQ (YoY)15.87%
ROA (Last FY)-201.46%
Revenue Growth TTM (YoY)81.20%
EBITD / Share (TTM)$-9.32
ROE (5Y Avg)-194.14%
Operating Margin (TTM)-1548.96%
Cash Flow / Share (Annual)$-10.28
P/B Ratio0.54x
P/B Ratio (Quarterly)0.81x
Net Income / Employee (Annual)$-1
EV / Revenue (TTM)-0.89x
Net Interest Coverage (TTM)-5.11x
ROA (TTM)-173.34%
EPS Incl Extra (Annual)$-19.68
Current Ratio (Annual)9.70x
Quick Ratio (Quarterly)5.44x
3-Month Avg Trading Volume0.74M
52-Week Price Return-75.52%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.01
P/S Ratio (Annual)3.87x
Asset Turnover (Annual)0.28x
52-Week High$13.23
Operating Margin (5Y Avg)-584.97%
EPS Excl Extra (Annual)$-19.68
26-Week Price Return-66.56%
Quick Ratio (Annual)7.61x
13-Week Price Return-23.91%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)5.86x
Enterprise Value$-0.428
Revenue / Share Growth (5Y)-10.27%
Asset Turnover (TTM)0.11x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)1.45x
Pretax Margin (Annual)-725.00%
Cash / Share (Annual)$3.59
3-Month Return Std Dev90.97%
Gross Margin (5Y Avg)2.21%
Net Income / Employee (TTM)$-1
ROE (Last FY)-223.08%
Net Interest Coverage (Annual)-2.10x
EPS Basic Excl Extra (Annual)$-19.68
Receivables Turnover (TTM)34.43x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-9.87
Receivables Turnover (Annual)6.42x
ROI (TTM)-202.20%
P/S Ratio (TTM)6.27x
Pretax Margin (5Y Avg)-614.40%
Revenue / Share (Annual)$2.71
Tangible BV / Share (Annual)$37.51
Price vs S&P 500 (52W)-105.35%
Year-to-Date Return-27.59%
5-Day Price Return9.38%
EPS Normalized (Annual)$-19.68
ROA (5Y Avg)-165.61%
Net Profit Margin (Annual)-725.00%
Month-to-Date Return18.54%
Cash Flow / Share (TTM)$-14.54
EBITD / Share (Annual)$-19.69
Operating Margin (Annual)-725.77%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-194.14%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-9.87
P/TBV (Quarterly)1.36x
P/B Ratio (Annual)1.13x
Inventory Turnover (TTM)2.07x
Pretax Margin (TTM)-1557.26%
Book Value / Share (Annual)$4.55
Price vs S&P 500 (13W)-24.60%
Beta1.95x
Revenue / Share (TTM)$0.36
ROE (TTM)-202.20%
52-Week Low$0.72
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
TIVCTivic Health Systems, Inc. Common Stock | 6.27x | 13.18% | -58.09% | -1548.96% | $1.13 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.65 |
MASIMasimo Corporation | 6.12x | 5.95% | 61.90% | 20.30% | $178.29 |
TMDXTransMedics Group, Inc. Common Stock | 6.58x | 88.21% | 59.92% | 17.93% | $109.12 |
LIVNLivaNova PLC Ordinary Shares | 2.56x | 8.24% | 68.04% | 14.09% | $65.01 |
ITGRInteger Holdings Corporation | 1.63x | 11.55% | 27.39% | 11.90% | $88.37 |
AXGNAxogen, Inc. Common Stock | 7.92x | 14.93% | 74.31% | -3.49% | $37.37 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $37.91 |
BLFSBioLife Solutions Inc. | 10.59x | 14.87% | 64.56% | -17.26% | $20.85 |
INMDInMode Ltd. Ordinary Shares | 2.45x | 12.45% | 78.54% | 23.05% | $14.33 |
CBLLCeriBell, Inc. Common Stock | 8.68x | — | 87.89% | -65.57% | $20.74 |
About
Tivic Health Systems develops non-invasive bioelectronic medicine devices that activate the body's natural healing mechanisms using programmable, ultra-low current electrical stimulation. The company offers a drug-free alternative to traditional pharmaceutical treatments across multiple disease indications. Its lead product, ClearUP Sinus Relief, is a handheld device designed to treat sinus congestion and pain associated with allergies, chronic sinusitis, infections, and cold/flu conditions.